NorthWest Biotherapeutics Inc (NWBO)

[dennisdave]

The average time to publication is 300 days. If you read the study, the 300 days was measured from when the company gained full access to all data

I suggest you read Vubrus post again from Dec 19 2020
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=160341086

Vubru has a lot of experience in submitting scientific medical journal articles. Everyone was in full agreement when he laid out that in his experience a journal about the DCVAX L trial should/could be available with a NEJM or Lancet TWO MONTHS after the company has been fully exposed to the data.

Unless you think Vubro (prof in his field) states nonsense. I suspect he sold for the reason that is now the subject of the discussion.
So there is that.

Second. There is literally NO indication of any medical trial being delayed as a publication in any medical journal. NWBO must be different. Alas.

Third. On March 16 NWBO stated in the coming months. I can't for the life of me not imagine they said that not being exposed to data yet. So calculated from March 16 + 300 days is way too late still
.